At the news
? NEUTRALIMPACT 2/10 8-K filed Jun 29, 2026 at 17:02 ET
Protara Therapeutics disclosed the resignation of Chief Medical Officer Leonardo Viana Nicacio, M.D., effective June 26, 2026, to pursue other opportunities. His responsibilities will be absorbed by existing clinical leadership, including Carla Beckham, M.D. and Jacqueline Zummo, Ph.D. This is a routine officer departure with no immediate financial or operational impact.
- Chief Medical Officer Leonardo Viana Nicacio resigned effective June 26, 2026 to explore other opportunities.
- Duties will be subsumed by Lead Medical Director Carla Beckham, M.D. under oversight of Chief R&D Officer Jacqueline Zummo, Ph.D.
- No replacement CMO has been named; no compensation or employment agreement details were disclosed.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access